These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23764418)

  • 1. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
    Wolfisberg R; Ruprecht N; Kempf C; Ros C
    J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.
    Wong S; Zhi N; Filippone C; Keyvanfar K; Kajigaya S; Brown KE; Young NS
    J Virol; 2008 Mar; 82(5):2470-6. PubMed ID: 18160440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
    Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
    J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.
    Chen AY; Kleiboeker S; Qiu J
    PLoS Pathog; 2011 Jun; 7(6):e1002088. PubMed ID: 21698228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globoside Is Dispensable for Parvovirus B19 Entry but Essential at a Postentry Step for Productive Infection.
    Bieri J; Ros C
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effect of cidofovir on parvovirus B19 replication.
    Bonvicini F; Bua G; Manaresi E; Gallinella G
    Antiviral Res; 2015 Jan; 113():11-8. PubMed ID: 25446336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
    Janovitz T; Wong S; Young NS; Oliveira T; Falck-Pedersen E
    Virology; 2017 Nov; 511():40-48. PubMed ID: 28806616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Cell-Based Detection of Parvovirus B19V Infectious Units According to Cell Cycle Status.
    Ducloux C; You B; Langelé A; Goupille O; Payen E; Chrétien S; Kadri Z
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33353185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells.
    Bonvicini F; Bua G; Manaresi E; Gallinella G
    Virus Res; 2016 Jul; 220():47-51. PubMed ID: 27071853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.
    Leisi R; Ruprecht N; Kempf C; Ros C
    J Virol; 2013 Dec; 87(24):13161-7. PubMed ID: 24067971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.
    Luo Y; Kleiboeker S; Deng X; Qiu J
    J Virol; 2013 Dec; 87(23):12766-75. PubMed ID: 24049177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of brincidofovir on parvovirus B19.
    Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
    Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity.
    Bönsch C; Kempf C; Ros C
    J Virol; 2008 Dec; 82(23):11784-91. PubMed ID: 18815302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
    Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
    Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Receptor-Binding Domain in the VP1u Region of Parvovirus B19.
    Leisi R; Di Tommaso C; Kempf C; Ros C
    Viruses; 2016 Feb; 8(3):61. PubMed ID: 26927158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VP1u Receptor Restricts Parvovirus B19 Uptake to Permissive Erythroid Cells.
    Leisi R; Von Nordheim M; Ros C; Kempf C
    Viruses; 2016 Sep; 8(10):. PubMed ID: 27690083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
    Zou W; Wang Z; Xiong M; Chen AY; Xu P; Ganaie SS; Badawi Y; Kleiboeker S; Nishimune H; Ye SQ; Qiu J
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
    Bua G; Manaresi E; Bonvicini F; Gallinella G
    PLoS One; 2016; 11(2):e0148547. PubMed ID: 26845771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Endothelial Regeneration Through Human Parvovirus B19-Infected Circulating Angiogenic Cells in Patients With Cardiomyopathy.
    Schmidt-Lucke C; Zobel T; Schrepfer S; Kuhl U; Wang D; Klingel K; Becher PM; Fechner H; Pozzuto T; Van Linthout S; Lassner D; Spillmann F; Escher F; Holinski S; Volk HD; Schultheiss HP; Tschope C
    J Infect Dis; 2015 Oct; 212(7):1070-81. PubMed ID: 25805750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Replication and Infection of Human Parvovirus B19.
    Ganaie SS; Qiu J
    Front Cell Infect Microbiol; 2018; 8():166. PubMed ID: 29922597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.